Company: SRPT
Filing Date: 2025-05-06
Form Type: 10-Q
Source: 0000950170-25-064412
Chunk: 6

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-05-06
Form: 10-Q
Item: Part I, Item 1
Chunk 6
---
400

     47,400

     Other non-current liabilities

     927

     1,750

     Total liabilities

     2,322,664

     2,435,431

     Commitments and contingencies (Note 16)

     Stockholders’ equity:

     Preferred stock, $0.0001 par value, 3,333,333 shares authorized; none issued and   outstanding

     —

     —

     Common stock, $0.0001 par value, 198,000,000 shares authorized; 98,254,898   and 96,900,496 issued and outstanding at March 31, 2025, and   December 31, 2024, respectively

     10

     10

     Additional paid-in capital

     5,801,161

     5,738,924

     Accumulated other comprehensive income (loss), net of tax

     34

     (218
     )

     Accumulated deficit

     (4,658,482
     )

     (4,210,974
     )

     Total stockholders’ equity

     1,142,723

     1,527,742

     Total liabilities and stockholders’ equity
      
     $
     3,465,387

     $
     3,963,173

See accompanying notes to unaudited condensed consolidated financial statements.